|
Each protocol has its own individual consent form. The links below lead to a printable version of each consent form.1. WBTT + 5FU + Doxil + Interferon protocol consent form
Phase II, non-randomized study for metastatic, resistant breast, endometrial, ovarian and cervical cancers.
2. WBTT + Cisplatin + Gemcitabine + Interferon - A protocol consent form
Phase II, non-randomized study for gastric, liver, lung, and head & neck cancers, as well as melanoma and cholangioma.
3. WBTT + Cisplatin + Gemcitabine + Interferon - B protocol consent formPhase II, non-randomized study for locally advanced and metastatic pancreas cancer.
Created in the Division of Oncology at The University of Texas Houston Medical School
MSB 5.281, 6431 Fannin, Houston, TX 77030; Tel: 713-500-6821
Last updated on
March 22, 2009
email questions to the webmaster at oncologyweb
The content of these pages is intended for information and educational purposes. It should not be construed as medical diagnosis or treatment.